Correction to: PET imaging of sympathetic innervation with [18F]Flubrobenguane vs [11C]mHED in a patient with ischemic cardiomyopathy

At time of initial publication, the USAN Council had assigned the generic name for LMI1195 as Flurobenguan. However, the Council has since changed and finalized this compound name as Flubrobenguane which is recommended as the generic name to be used in the future.

Saved in:
Bibliographic Details
Published inJournal of nuclear cardiology Vol. 27; no. 2; p. 702
Main Authors Zelt, Jason G.E., Mielniczuk, Lisa M., Orlandi, Cesare, Robinson, Simon, Hadizad, Tayebeh, Walter, Olga, Garrard, Linda, Beanlands, Rob S.B., deKemp, Robert A.
Format Journal Article
LanguageEnglish
Published Cham Elsevier Inc 01.04.2020
Springer International Publishing
Springer Nature B.V
Subjects
Cardiology
Correction
Imaging
Medicine
Medicine & Public Health
Nuclear Medicine
Radiology
Online AccessGet full text

Cover

More Information
Summary:At time of initial publication, the USAN Council had assigned the generic name for LMI1195 as Flurobenguan. However, the Council has since changed and finalized this compound name as Flubrobenguane which is recommended as the generic name to be used in the future.
Bibliography:erratum
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Correction/Retraction-1
ObjectType-Feature-3
content type line 23
ISSN:1071-3581
1532-6551
DOI:10.1007/s12350-019-02018-x